Literature DB >> 22399610

Expression of cathepsin-D in primary breast cancer and corresponding local recurrence or metastasis: an immunohistochemical study.

D Dian1, T Vrekoussis, N Shabani, I Mylonas, C Kuhn, C Schindlbeck, I Navrozoglou, K Friese, A Makrigiannakis, U Jeschke.   

Abstract

BACKGROUND/AIM: The role of cathepsin-D is well established in breast cancer progression, being correlated with worse clinical outcomes. However, to our knowledge, no study has been performed investigating its expression in primary breast cancer tumors and their corresponding recurrences or metastasis.
MATERIALS AND METHODS: Tissue sections from ten breast cancer cases and their corresponding local recurrences and six breast cancer cases and their corresponding metastases were immunohistochemically assessed for cathepsin-D reactivity. Cases diagnosed as either ductal carcinoma in situ (n=7), or breast carcinoma with no evidence of local recurrence or metastasis during follow-up (n=8) served as controls.
RESULTS: Cathepsin-D was significantly up-regulated in all the study groups compared to controls. No difference was found between primary tumors and their corresponding recurrences or metastases.
CONCLUSION: Cathepsin-D-expressing breast cancer cells seem to be involved in local recurrence or metastasis formation. Large series are needed to further verify this result with the aim of possible future molecular intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399610

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Association of ICAM-1, VCAM-1, CYCLIN D1 and Cathepsin D with Clinicopathological Parameters in Breast Carcinoma; an Immunohistochemical Study.

Authors:  Özgür Külahcı; H Hasan Esen; Elife Asut; Salim Güngör
Journal:  J Breast Health       Date:  2017-01-01

2.  'Patchiness' and basic cancer research: unravelling the proteases.

Authors:  Surinder M Soond; Maria V Kozhevnikova; Andrey A Zamyatnin
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

Review 3.  Cathepsins mediate tumor metastasis.

Authors:  Gong-Jun Tan; Zheng-Ke Peng; Jin-Ping Lu; Fa-Qing Tang
Journal:  World J Biol Chem       Date:  2013-11-26

4.  Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers.

Authors:  Hasitha Shilpa Anantaraju; Madhu Babu Battu; Srikant Viswanadha; Dharmarajan Sriram; Perumal Yogeeswari
Journal:  Mol Divers       Date:  2015-11-13       Impact factor: 2.943

Review 5.  Metastatic and triple-negative breast cancer: challenges and treatment options.

Authors:  Sumayah Al-Mahmood; Justin Sapiezynski; Olga B Garbuzenko; Tamara Minko
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

6.  Evaluation of serum cathepsin D concentrations in coronary artery disease.

Authors:  Amir Hooshang Mohammadpour; Zakieh Salehinejad; Sepideh Elyasi; Mohsen Mouhebati; Seyed Reza Mirhafez; Sara Samadi; Majid Ghayour-Mobarhan; Gordon Ferns; Amirhossein Sahebkar
Journal:  Indian Heart J       Date:  2018-01-08

7.  Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma.

Authors:  Haihong Pu; Qingyuan Zhang; Chunbo Zhao; Lei Shi; Yan Wang; Jingxuan Wang; Minghui Zhang
Journal:  World J Surg Oncol       Date:  2015-11-25       Impact factor: 2.754

Review 8.  Adaptation of the Golgi Apparatus in Cancer Cell Invasion and Metastasis.

Authors:  Sarah Bui; Isabel Mejia; Begoña Díaz; Yanzhuang Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.